MetaCap

Eloxx Pharmaceuticals (ELOX) vs Greenland Mines (GRML)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Greenland Mines is the larger company by market cap ($78.5 million vs $61.3 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELOX+35.15%GRML-61.00%
+99%+5%-90%
Jun 9, 20261 yearOct 7, 2026
ELOX+10.06%GRML-60.20%
+62%-13%-87%
Jun 8, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELOX versus GRML key metrics
MetricELOXGRML
Share price$15.18$5.88
Market cap$61.27M$78.48M
1-day change+2.02%+0.86%
YTD return—-59.65%
1-year return—-80.37%
P/E ratio (TTM)4.31—
EPS (TTM)$3.52$-9.74
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$23.40$37.00
52-week low$8.20$2.82
Distance from 52-week high-35.13%-84.11%
Average volume46.44K7.89M
Shares outstanding4.04M13.35M
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

ELOX vs GRML FAQ

Which is bigger, Eloxx Pharmaceuticals or Greenland Mines?

Greenland Mines (GRML) is larger, with a market capitalization of $78.48M compared with $61.27M for Eloxx Pharmaceuticals (ELOX).

Are Eloxx Pharmaceuticals and Greenland Mines in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons